One of the largest real-world studies on chronic pelvic pain treatment has been published, evaluating outcomes from 1,517 women treated with the PRM Protocol™. The research demonstrated meaningful improvements in pain, bladder and bowel function, sleep, work productivity, sexual function, emergency room utilization, and opioid use. These findings help advance women's health research and reinforce the importance of evidence-based, multidisciplinary care for chronic pelvic pain.
The study evaluated treatment outcomes in 1,517 women with chronic pelvic pain treated using the PRM Protocol™. Researchers examined changes in pain, daily function, healthcare utilization, opioid use, and quality of life to better understand real-world patient outcomes.
The published study included 1,517 women with chronic pelvic pain, making it one of the largest real-world datasets evaluating treatment outcomes in female pelvic pain.
Researchers observed improvements in pain, bladder and bowel function, walking and mobility, sleep, sexual function, work productivity, emergency room visits, and opioid use following treatment.
Chronic pelvic pain affects millions of women but has historically received limited research attention. Large real-world studies help improve understanding of treatment outcomes, guide clinical care, and support better access to evidence-based therapies for patients living with chronic pelvic pain.
The PRM Protocol™ is a minimally invasive, office-based treatment designed to address pelvic floor dysfunction, pelvic nerve sensitization, and other neuromusculoskeletal contributors to chronic pelvic pain through ultrasound-guided peripheral nerve blocks and trigger point injections.